(Q38150419)

29 August 2017

title

Pharmacokinetic evaluation of desogestrel as a female contraceptive (English)

1 reference

29 August 2017

1 reference

Angelo Cagnacci

2

0 references

author name string

Giovanni Grandi

series ordinal

1

1 reference

29 August 2017

Annibale Volpe

series ordinal

3

1 reference

29 August 2017

language of work or name

English

0 references

publication date

9 October 2013

1 reference

Expert Opinion on Drug Metabolism & Toxicology

29 August 2017

published in

1 reference

29 August 2017

volume

10

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

1-10

1 reference

Seventy-five microgram desogestrel minipill, a new perspective in estrogen-free contraception

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Metabolism of a new synthetic progestagen, Org 2969, in female volunteers. Pharmacokinetics after an oral dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Metabolism of a new synthetic progestagen, Org 2969, by human liver in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Excretion and metabolism of desogestrel in healthy postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Randomized, Crossover and Single-Dose Bioquivalence Study of Two Oral Desogestrel Formulations (Film-Coated Tablets of 75 μg) in Healthy Female Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Metabolic effects of implantable steroid contraceptives for women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Implanon contraceptive implants: effects on carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Effect on insulin sensitivity of Implanon vs. GnRH agonist in women with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Classification and pharmacology of progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Drug safety evaluation of desogestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Oral contraceptives and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Thrombotic stroke and myocardial infarction with hormonal contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Toxicology of progestogens of implantable contraceptives for women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2013.844229

Pharmacokinetics of Implanon. An integrated analysis

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1016/S0010-7824(98)00120-6

Identifiers

DOI

10.1517/17425255.2013.844229

1 reference

29 August 2017

1 reference